Circulating atrial natriuretic peptides in hyperthyroidism and hypothyroidism

This publication has 18 references indexed in Scilit:

• Effects of high-sodium and low-sodium intake on circulating atrial natriuretic peptides in salt-sensitive patients with systemic hypertension
  The American Journal of Cardiology, 1987
• Circulating atrial natriuretic polypeptide in essential hypertension
  American Heart Journal, 1987
• Effect of exercise on circulating atrial natriuretic polypeptide in valvular heart disease
  The American Journal of Cardiology, 1986
• An Accelerated Increase of Circulating Atrial Natriuretic Polypeptide in Salt-Loaded Spontaneously Hypertensive Rats
  Hormone and Metabolic Research, 1986
• Atrial natriuretic polypeptide in atria and plasma in experimental hyperthyroidism and hypothyroidism
  Biochemical and Biophysical Research Communications, 1986
• Plasma Concentration of Atrial Natriuretic Factor in a Patient with Paroxysmal Atrial Tachycardia
  New England Journal of Medicine, 1985
• Atrial natriuretic factor—a circulating hormone stimulated by volume loading
  Nature, 1985
• Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility.
  Hypertension, 1984
• Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP)
  Biochemical and Biophysical Research Communications, 1984
• A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
  Life Sciences, 1981